Since our unpublished data showed the expression of TRAIL-R4 in different tumor cells, we wondered whether this receptor could at least be partially responsible for the establishment of a resistant phenotype of these cells to γδ T cell-induced cytotoxicity as we recently reported (48, 56). Here, TNFRSF10D is linked to neoplasm.